Jim Thorpe, PA, United States of America

Garry Thomas Gwozdz

This inventor holds 25 USPTO granted patents and 14 published patent applications, plus 5 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Neurelis, Inc., Particle Sciences, Inc., Sunsmart, Inc.. Active years: 1990-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Garry Thomas Gwozdz. Retrieved from https://idiyas.com/inventor/garry-thomas-gwozdz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 

% Patents Active = 88.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 180(Granted Patents)


Location History:

  • Nazareth, PA (US) (1990 - 2021)
  • Bethlehem, PA (US) (2014 - 2022)
  • Jim Thorpe, PA (US) (2014 - 2023)

Company Filing History:


Years Active: 1990-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Benzodiazepine Compositions
Topical Avermectin
Drug Delivery Particles
Pharmaceutical Compositions
Active Agent Nanoparticles
Encapsulated Ingredients
Aqueous Suspensions
Anesthetic Composition
Increased Density Molding
Stabilized Ascorbic Acid
Hydrophilic Materials
UV Sunblock Compositions
25 patents (USPTO):Explore Patents

Title: **Garry Thomas Gwozdz: A Pioneering Inventor in Pharmaceutical Innovations**

Introduction

Garry Thomas Gwozdz is a notable inventor based in Jim Thorpe, PA, USA. With a remarkable portfolio that includes 11 patents, Gwozdz has significantly contributed to the field of pharmaceuticals through his innovative approaches to drug composition and delivery systems.

Latest Patents

Gwozdz's latest inventions showcase his expertise in pharmaceutical formulations. One of his recent patents involves the administration of benzodiazepine compositions, which relates to pharmaceutical formulations designed for nasal administration. This innovation not only enhances the delivery methods for benzodiazepine drugs but also provides new methods for producing and utilizing these compositions. Another significant patent focuses on formulations of tegavivint and related compounds. This patent details methods of creating these formulations and outlines their potential applications in treating various medical conditions.

Career Highlights

Throughout his career, Gwozdz has been associated with several esteemed companies, enhancing his professional journey. He has had impactful roles at Particle Sciences, Inc. and Hale Biopharma Ventures, LLC. His work in these organizations allowed him to advance his research and contribute to groundbreaking pharmaceutical developments.

Collaborations

Gwozdz has collaborated with skilled professionals in his field, including notable coworkers Mark Mitchnick and Andrew Loxley. These partnerships have helped drive innovation and development in the pharmaceutical sector, reflecting Gwozdz's commitment to advancing healthcare solutions.

Conclusion

With his extensive patent portfolio and dedication to innovation, Garry Thomas Gwozdz continues to be a significant figure in the pharmaceutical industry. His contributions not only enhance drug delivery methods but also pave the way for new treatments, exemplifying the innovative spirit that drives progress in healthcare. As he continues to develop novel solutions, Gwozdz’s work remains pivotal in enhancing patient care and advancing medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…